ARCHIVES

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

This article is from The Cancer Letter archive.

Vol. 25 No. 40 | October 22, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

Consolidation Unlikely to Save Money

December 17, 2010

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009